Clinical Observation On The Effect Of Huatan Zhifeng Decoction In Treating Feng Deficiency Syndrome Of Acute Stage Of Ischemic Stroke

Purpose:Clinical efficacy and safety of the treatment of acute ischemic stroke(wind phlegm Blocking Collaterals) in the treatment of ischemic apoplexy. Material and method:In this study, 60 patients were derived in March 2014 and 2015, October in Liaoning University of traditional Chinese Medicine Affiliated Second Hospital of encephalopathy of hospitalized patients, time of onset were within 2 weeks and syndrome differentiation of traditional Chinese medicine for ischemic stroke(Meridian) wind phlegm syndrome. 60 patients were randomly divided into treatment group 30, 30 in control group.. The control group was given routine treatment of Western Medicine Department of internal medicine; on the basis of the treatment group, the treatment group was added to take out the wind and dredging collaterals soup, taking 14 D. Patients with stable disease after two groups of patients can be according to the "guidelines for prevention and treatment of cerebrovascular disease in China" to carry out rehabilitation. Before treatment, 14 days after treatment and 90 days after the onset of clinical neurological impairment score, daily activity ability Rating Scale(Barthel) score, TCM syndrome score, NIHSS score. Results: 1. The daily life ability(Barthel index) curative effect comparison: the treatment group treatment 14 day and the 90 day after the disease improvement rate respectively is 66.67%, 76.67%; the control group respectively is 53.33%, 56.67%, the treatment group improvement rate all is superior to the control group. 2.Nerve function defect curative effect comparison: treatment 14 day treatment group improvement rate is 96.67%, the control group is 73.33%, the improvement rate of the treatment group is better than the control group. 3.Improved Rankin scale effect comparison:: the treatment group for 14 days and 90 days after the onset of the improvement rate were 80%, 83.33%; the control group was 60%,63.33% The improvement rate of the treatment group was higher than that of the control group. 4.Comparison of TCM syndrome curative effect: the treatment group was 14, the efficiency was 76.67%, the control group was 43.33%, the treatment group was more efficient than the control group. 5.Two groups of patients during the medication did not appear adverse reactions, not due to adverse events and stop medication. Conclusion:To improve the clinical symptoms of patients with acute ischemic stroke, and to promote the recovery of neurological function, improve the performance of traditional Chinese medicine, it is worthy of clinical application.